Capital Advantage’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.32M | Sell |
5,188
-151
| -3% | -$35.2K | 0.16% | 57 |
|
|
2026
Q1 | $1.31M | Sell |
5,339
-20
| -0.4% | -$4.66K | 0.17% | 56 |
|
|
2025
Q4 | $1.11M | Buy |
5,359
+590
| +12% | +$117K | 0.15% | 59 |
|
|
2025
Q3 | $884K | Buy |
4,769
+7
| +0.1% | +$1.2K | 0.13% | 66 |
|
|
2025
Q2 | $727K | Sell |
4,762
-148
| -3% | -$22.7K | 0.12% | 73 |
|
|
2025
Q1 | $710K | Hold |
4,910
| – | – | 0.13% | 69 |
|
|
2024
Q4 | $710K | Buy |
+4,910
| New | +$761K | 0.13% | 69 |
|
|
2021
Q2 | – | Sell |
-6,228
| Closed | -$1.02M | – | 77 |
|
|
2021
Q1 | $1.02M | Buy |
6,228
+244
| +4% | +$39.5K | 0.28% | 37 |
|
|
2020
Q4 | $947K | Buy |
5,984
+101
| +2% | +$14.9K | 0.28% | 35 |
|
|
2020
Q3 | $870K | Sell |
5,883
-119
| -2% | -$17.6K | 0.29% | 35 |
|
|
2020
Q2 | $844K | Sell |
6,002
-303
| -5% | -$44.2K | 0.3% | 36 |
|
|
2020
Q1 | $958K | Buy |
6,305
+138
| +2% | +$19.6K | 0.37% | 31 |
|
|
2019
Q4 | $915K | Sell |
6,167
-100
| -2% | -$13.6K | 0.29% | 33 |
|
|
2019
Q3 | $811K | Buy |
+6,267
| New | +$826K | 0.28% | 35 |
|
|
2019
Q1 | $978K | Sell |
6,999
-961
| -12% | -$129K | 0.35% | 36 |
|
|
2018
Q4 | $1.03M | Buy |
7,960
+48
| +0.6% | +$6.7K | 0.39% | 28 |
|
|
2018
Q3 | $1.09M | Sell |
7,912
-1,524
| -16% | -$203K | 0.25% | 31 |
|
|
2018
Q2 | $1.15M | Buy |
9,436
+394
| +4% | +$49.2K | 0.27% | 31 |
|
|
2018
Q1 | $1.16M | Sell |
9,042
-889
| -9% | -$120K | 0.28% | 27 |
|
|
2017
Q4 | $1.39M | Sell |
9,931
-395
| -4% | -$55K | 0.36% | 27 |
|
|
2017
Q3 | $1.34M | Sell |
10,326
-29
| -0.3% | -$3.84K | 0.34% | 27 |
|
|
2017
Q2 | $1.37M | Buy |
10,355
+73
| +0.7% | +$9.31K | 0.36% | 27 |
|
|
2017
Q1 | $1.28M | Buy |
10,282
+518
| +5% | +$61.9K | 0.35% | 29 |
|
|
2016
Q4 | $1.13M | Sell |
9,764
-42
| -0.4% | -$4.85K | 0.33% | 32 |
|
|
2016
Q3 | $1.16M | Buy |
9,806
+198
| +2% | +$24K | 0.32% | 31 |
|
|
2016
Q2 | $1.17M | Buy |
9,608
+52
| +0.5% | +$5.91K | 0.34% | 32 |
|
|
2016
Q1 | $1.03M | Sell |
9,556
-25
| -0.3% | -$2.59K | 0.37% | 34 |
|
|
2015
Q4 | $984K | Buy |
9,581
+305
| +3% | +$30.7K | 0.33% | 37 |
|
|
2015
Q3 | $866K | Buy |
9,276
+840
| +10% | +$81.3K | 0.34% | 36 |
|
|
2015
Q2 | $822K | Sell |
8,436
-161
| -2% | -$16.1K | 0.32% | 35 |
|
|
2015
Q1 | $865K | Buy |
8,597
+5
| +0.1% | +$508 | 0.36% | 31 |
|
|
2014
Q4 | $898K | Buy |
8,592
+375
| +5% | +$39.5K | 0.37% | 30 |
|
|
2014
Q3 | $876K | Sell |
8,217
-73
| -0.9% | -$7.57K | 0.46% | 24 |
|
|
2014
Q2 | $867K | Buy |
8,290
+24
| +0.3% | +$2.43K | 0.48% | 22 |
|
|
2014
Q1 | $812K | Buy |
8,266
+702
| +9% | +$65.1K | 0.57% | 21 |
|
|
2013
Q4 | $693K | Buy |
+7,564
| New | +$697K | 0.47% | 22 |
|
Other funds holding JNJ
Capital Advantage's JNJ Position: Q2 2026 in Review
Capital Advantage reduced its Johnson & Johnson (JNJ) stake by 2.8% in Q2 2026, selling an estimated $35.2K and leaving 5,188 shares worth $1.32M. The position accounts for 0.16% of the portfolio, ranked #57.
Capital Advantage first reported a position in JNJ in Q4 2013 and has held it in 36 quarters since. The position peaked at $1.39M in Q4 2017. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Capital Advantage held 5,188 shares of Johnson & Johnson worth $1.32M as of Q2 2026.
- Capital Advantage sold 151 Johnson & Johnson shares in Q2 2026, an estimated $35.2K.
- Johnson & Johnson made up 0.16% of Capital Advantage's portfolio in Q2 2026, its #57 holding.
- Capital Advantage first reported a position in Johnson & Johnson in Q4 2013 and has held it in 36 quarters since.
- Capital Advantage's Johnson & Johnson position peaked at $1.39M in Q4 2017.
- 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Capital Advantage's 13F filing for Q2 2026, filed 13 Jul 2026.